CYTOKINETICS, INCORPORATED Increase (Decrease) in Restricted Cash
CYTOKINETICS, INCORPORATED (CYTK) reported Increase (Decrease) in Restricted Cash of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2015-03-06
- CYTOKINETICS, INCORPORATED increase (decrease) in restricted cash for the quarter ending 2012-12-31 was $0.00.
- CYTOKINETICS, INCORPORATED increase (decrease) in restricted cash for the quarter ending 2012-09-30 was $0.00.
- CYTOKINETICS, INCORPORATED increase (decrease) in restricted cash for the quarter ending 2012-06-30 was -$51.00K.
- CYTOKINETICS, INCORPORATED increase (decrease) in restricted cash for the quarter ending 2012-03-31 was -$145.00K.
- CYTOKINETICS, INCORPORATED increase (decrease) in restricted cash for fiscal 2014 was $0.00.
- CYTOKINETICS, INCORPORATED increase (decrease) in restricted cash for fiscal 2013 was $0.00.
- CYTOKINETICS, INCORPORATED increase (decrease) in restricted cash for fiscal 2012 was -$196.00K.
- CYTOKINETICS, INCORPORATED increase (decrease) in restricted cash for fiscal 2011 was -$592.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month | Increase (Decrease) in Restricted Cash 167 month | Increase (Decrease) in Restricted Cash 170 month | Increase (Decrease) in Restricted Cash 173 month | Increase (Decrease) in Restricted Cash 176 month |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-06 | |||||||
| 2013-12-31 | $0.00 10-K · filed 2015-03-06 | |||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | $0.00 derived: sum of 2 quarters · filed 2015-03-06 | -$51.00K derived: sum of 3 quarters · filed 2015-03-06 | -$196.00K 10-K · filed 2015-03-06 | ||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | -$51.00K derived: sum of 2 quarters · filed 2013-11-06 | -$196.00K 10-Q · filed 2013-11-06 | -$215.00K derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2012-06-30 | -$51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$196.00K 10-Q · filed 2013-08-07 | -$215.00K derived: sum of 3 quarters · filed 2014-03-07 | -$439.00K derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2012-03-31 | -$145.00K 10-Q · filed 2013-05-08 | -$164.00K derived: sum of 2 quarters · filed 2014-03-07 | -$388.00K derived: sum of 3 quarters · filed 2014-03-07 | -$388.00K derived: sum of 4 quarters · filed 2014-03-07 | $51.00K 10-Q · filed 2012-05-04 | |||
| 2011-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$243.00K derived: sum of 2 quarters · filed 2014-03-07 | -$243.00K derived: sum of 3 quarters · filed 2014-03-07 | -$592.00K 10-K · filed 2014-03-07 | $196.00K 10-K · filed 2012-03-13 | |||
| 2011-09-30 | -$224.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$224.00K derived: sum of 2 quarters · filed 2012-11-07 | -$573.00K 10-Q · filed 2012-11-07 | -$573.00K derived: sum of 4 quarters · filed 2013-03-15 | $215.00K 10-Q · filed 2011-11-04 | |||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | -$349.00K 10-Q · filed 2012-08-06 | -$349.00K derived: sum of 3 quarters · filed 2013-03-15 | -$794.00K derived: sum of 4 quarters · filed 2013-03-15 | $439.00K 10-Q · filed 2011-08-04 | |||
| 2011-03-31 | -$349.00K 10-Q · filed 2012-05-04 | -$349.00K derived: sum of 2 quarters · filed 2013-03-15 | -$794.00K derived: sum of 3 quarters · filed 2013-03-15 | |||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$445.00K derived: sum of 2 quarters · filed 2013-03-15 | -$886.00K 10-K · filed 2013-03-15 | |||||
| 2010-09-30 | -$445.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$886.00K 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | -$441.00K 10-Q · filed 2011-08-04 | |||||||
| 2009-12-31 | -$1.08M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |